Peripheral and thymic Foxp3+ regulatory T cells in search of origin, distinction, and function

Frontiers in Immunology

Volumn 4, Issue AUG, 2013, Pages

  Dhamne, Chetan ^a   Chung, Yeonseok ^b   Alousi, Amin Majid ^c   Cooper, Laurence J N ^c   Tran, Dat Quoc ^b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Autoimmunity; Foxp3; Immunological tolerance; Regulatory T cells; Tregs

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; NEUROPILIN 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; ZINC FINGER PROTEIN;

ABORTION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LAMINA PROPRIA; LYMPH NODE; NONHUMAN; PHENOTYPE; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 84883737369     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00253     Document Type: Review

References (132)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol (1995) 155(3):1151-64.
2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Pillars article: immunologic self-1111tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. J Immunol (2011) 186(7):3808-21.
3. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 4(4):330-6. doi:10.1038/ni904
4. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science (2003) 299(5609):1057-61. doi:10.1126/science.1079490
5. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol (2003) 4(4):337-42. doi:10.1038/ni909
6. + natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci U S A (2008) 105(29):10113-8. doi:10.1073/pnas.0711106105
7. Benoist C, Mathis D. Treg cells, life history, and diversity. Cold Spring Harb Perspect Biol (2012) 4(9):a007021. doi:10.1101/cshperspect.a007021
8. + regulatory T cells in immune tolerance. Annu Rev Immunol (2012) 30:733-58. doi:10.1146/annurev-38immunol-020711-075043
9. Schmetterer KG, Neunkirchner A, Pickl WF. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J (2012) 26(6):2253-76. doi:10.1096/fj.11-193672
10. Yuan X, Malek TR. Cellular and molecular determinants for the development of natural and induced regulatory T cells. Hum Immunol (2012) 73(8):773-82. doi:10.1016/j.humimm.2012.05.010
11. Lin X, Chen M, Liu Y, Guo Z, He X, Brand D, et al. Advances in distinguishing natural from induced Foxp3(+) regulatory T cells. Int J Clin Exp Pathol (2013) 6(2):116-23.
12. Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol (2013) 14(4):307-8. doi:10.1038/ni.2554
13. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell (2008) 133(5):775-87. doi:10.1016/j.cell.2008.05.009
14. Sakaguchi S. Animal models of autoimmunity and their relevance to human diseases. Curr Opin Immunol (2000) 12(6):684-90. doi:10.1016/S0952-77915(00)00163-1
15. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature (2010) 463(7282):808-12. doi:10.1038/nature08750
16. Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature (2012) 482(7385):395-9. doi:10.1038/nature10772
17. Chaudhry A, Rudensky AY. Control of inflammation by integration of environmental cues by regulatory T cells. J Clin Invest (2013) 123(3):939-44. doi:10.1172/JCI57175
18. Zhou X, Bailey-8Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol (2009) 21(3):281-5. doi:10.1016/j.coi.2009.05.007
19. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity (2009) 30(5):646-55. doi:10.1016/j.immuni.2009.05.001
20. + regulatory T cells. Trends Mol Med (2012) 18(8):454-62.
21. + T regulatory cells. J Immunol (2010) 184(7):3433-41. doi:10.4049/jimmunol.0904028
22. + T regulatory cell subset in humans". J Immunol (2013) 190(9):4440-1. doi:10.4049/jimmunol.1390019
23. + human T regulatory cells during in vitro expansion. Blood (2012) 119(12):2810-8. doi:10.1182/blood-2011-09-377895
24. McClymont SA, Putnam AL, Lee MR, Esensten JH, Liu W, Hulme MA, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol (2011) 186(7):3918-26. doi:10.4049/jimmunol.1003099
25. + regulatory T cells. J Immunol (2012) 188(3):976-80. doi:10.4049/jimmunol.1102964
26. + T regulatory cell subset in humans. J Immunol (2013) 190(5):2001-8. doi:10.4049/jimmunol.1201379
27. + T regulatory cells in renal cell carcinoma co-200express Helios, indicating they could be derived from natural but not induced Tregs. Clin Immunol (2011) 140(3):218-22. doi:10.1016/j.clim.2011.04.014
28. + HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients. Transpl Int (2012) 25(12):1257-67. doi:10.1111/j.1432-22277.2012.01565.x
29. + Helios+ regulatory T cells are expanded in active systemic lupus erythematosus. Ann Rheum Dis (2013) 72:1549-58. doi:10.1136/annrheumdis-2012-202216
30. Semple K, Yu Y, Wang D, Anasetti C, Yu XZ. Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice. Biol Blood Marrow Transplant (2011) 17(3):309-18. doi:10.1016/j.bbmt.2010.12.710
31. Zhong H, Yazdanbakhsh K. Differential control of Helios(±) Treg development by monocyte subsets through disparate inflammatory cytokines. Blood (2013) 121(13):2494-502. doi:10.1182/blood-32012-11-469122
32. Baine I, Basu S, Ames R, Sellers RS, Macian F. Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. J Immunol (2013) 190(3):1008-16. doi:10.4049/jimmunol.1200792
33. Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, et al. TGF-10beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol (2004) 172(2):834-42.
34. Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, et al. Cord blood CD4(+)CD25(+)-8derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood (2005) 105(2):750-8. doi:10.1182/blood-2004-06-2467
35. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE (2008) 3(7):e2705. doi:10.1371/journal.pone.0002705
36. + regulatory T cells. Proc Natl Acad Sci U S A (2009) 106(32):13445-50. doi:10.1073/pnas.0901944106
37. Stockis J, Colau D, Coulie PG, Lucas S. Membrane protein GARP is a receptor for latent TGF-134beta on the surface of activated human Treg. Eur J Immunol (2009) 39(12):3315-22. doi:10.1002/eji.200939684
38. + regulatory T cells allows for their purification from expansion cultures. Blood (2009) 113(21):5125-33. doi:10.1182/blood-2009-01-199950
39. + regulatory T cells. Proc Natl Acad Sci U S A (2009) 106(32):13439-44. doi:10.1073/pnas.0901965106
40. Tran DQ. TGF-134beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol (2012) 4(1):29-37. doi:10.1093/jmcb/mjr033
41. Zhou AX, Kozhaya L, Fujii H, Unutmaz D. GARP-TGF-beta complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo. J Immunol (2013) 190(10):5057-64. doi:10.4049/jimmunol.1300065
42. Edwards JP, Fujii H, Zhou AX, Creemers J, Unutmaz D, Shevach EM. Regulation of the expression of GARP/Latent TGF-50beta1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation. J Immunol (2013) 190(11):5506-15. doi:10.4049/jimmunol.1300199
43. Mercer F, Kozhaya L, Unutmaz D. Expression and function of TNF and IL-551 receptors on human regulatory T cells. PLoS ONE (2010) 5(1):e8639. doi:10.1371/journal.pone.0008639
44. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol (2004) 34(3):623-30. doi:10.1002/eji.200324799
45. Corbel C, Lemarchandel V, Thomas-6Vaslin V, Pelus AS, Agboton C, Romeo PH. Neuropilin 1 and CD25 co-regulation during early murine thymic differentiation. Dev Comp Immunol (2007) 31(11):1082-94. doi:10.1016/j.dci.2007.01.009
46. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-101 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity (2008) 28(3):402-13. doi:10.1016/j.immuni.2008.01.012
47. + regulatory T cells impairs mouse melanoma growth. J Exp Med (2012) 209(11):2001-16. doi:10.1084/jem.20111497
48. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-4Llordella M, Bailey-Bucktrout S, et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med (2012) 209(10):1713-22; S1-19. doi:10.1084/jem.20120822
49. + T reg cells. J Exp Med (2012) 209(10):1723-42. S1, doi:10.1084/jem.20120914
50. Tran DQ, Shevach EM. Therapeutic potential of FOXP3(+) regulatory T cells and their interactions with dendritic cells. Hum Immunol (2009) 70(5):294-9. doi:10.1016/j.humimm.2009.02.007
51. + Treg. Eur J Immunol (2009) 39(6):1466-71. doi:10.1002/eji.200839040
52. Battaglia A, Buzzonetti A, Monego G, Peri L, Ferrandina G, Fanfani F, et al. Neuropilin-141 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology (2008) 123(1):129-38. doi:10.1111/j.1365-2567.2007.02737.x
53. Hsieh CS, Lee HM, Lio CW. Selection of regulatory T cells in the thymus. Nat Rev Immunol (2012) 12(3):157-67.
54. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol (2012) 30:531-64. doi:10.1146/annurev.immunol.25.022106.141623
55. Lee HM, Bautista JL, Scott-1Browne J, Mohan JF, Hsieh CS. A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity (2012) 37(3):475-86. doi:10.1016/j.immuni.2012.07.009
56. + regulatory but not conventional CD4+ thymocyte development. J Exp Med (2013) 210(4):675-81. doi:10.1084/jem.20122070
57. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-4tolerance. J Immunol (1999) 162(9):5317-26.
58. Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-53peptide. Nat Immunol (2001) 2(4):301-6. doi:10.1038/86302
59. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol (2002) 3(8):756-63.
60. Picca CC, Larkin J 3rd, Boesteanu A, Lerman MA, Rankin AL, Caton AJ. Role of TCR specificity in CD4+ CD25+ regulatory T-30cell selection. Immunol Rev (2006) 212:74-85. doi:10.1111/j.0105-2896.2006.00416.x
61. Thorstenson KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol (2001) 167(1):188-95.
62. Gottschalk RA, Corse E, Allison JP. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med (2010) 207(8):1701-11. doi:10.1084/jem.20091999
63. + regulatory T cell induction and expansion. J Immunol (2009) 183(8):4895-903. doi:10.4049/jimmunol.0901459
64. Molinero LL, Miller ML, Evaristo C, Alegre ML. High TCR stimuli prevent induced regulatory T cell differentiation in a NF-1kappaB-dependent manner. J Immunol (2011) 186(8):4609-17. doi:10.4049/jimmunol.1002361
65. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, et al. Peripheral education of the immune system by colonic commensal microbiota. Nature (2011) 478(7368):250-4. doi:10.1038/nature10434
66. + regulatory T-46cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A (2010) 107(27):12204-9. doi:10.1073/pnas.0909122107
67. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2011) 331(6015):337-41. doi:10.1126/science.1198469
68. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity (2000) 12(4):431-40. doi:10.1016/S1074-37613(00)80195-8
69. Cheng G, Yu A, Dee MJ, Malek TR. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development. J Immunol (2013) 190(4):1567-75. doi:10.4049/jimmunol.1201218
70. + regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol (2005) 6(11):1152-9. doi:10.1038/ni1264
71. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-11expressing regulatory T cells. Nat Immunol (2005) 6(11):1142-51. doi:10.1038/ni1263
72. Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol (2005) 6(2):152-62. doi:10.1038/ni1160
73. Zhang R, Huynh A, Whitcher G, Chang J, Maltzman JS, Turka LA. An obligate cell-11intrinsic function for CD28 in Tregs. J Clin Invest (2013) 123(2):580-93. doi:10.1172/JCI65013
74. Stritesky GL, Jameson SC, Hogquist KA. Selection of self-5reactive T cells in the thymus. Annu Rev Immunol (2012) 30:95-114. doi:10.1146/annurev-immunol-020711-075035
75. + T regulatory cells. J Immunol (2007) 178(7):4022-6.
76. Shevach EM, Tran DQ, Davidson TS, Andersson J. The critical contribution of TGF-402beta to the induction of Foxp3 expression and regulatory T cell function. Eur J Immunol (2008) 38(4):915-7. doi:10.1002/eji.200738111
77. Soligo M, Camperio C, Caristi S, Scotta C, Del Porto P, Costanzo A, et al. CD28 costimulation regulates FOXP3 in a RelA/NF-91kappaB-dependent mechanism. Eur J Immunol (2011) 41(2):503-13. doi:10.1002/eji.201040712
78. Guo F, Iclozan C, Suh WK, Anasetti C, Yu XZ. CD28 controls differentiation of regulatory T cells from naive CD4 T cells. J Immunol (2008) 181(4):2285-91.
79. Semple K, Nguyen A, Yu Y, Wang H, Anasetti C, Yu XZ. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood (2011) 117(11):3096-103. doi:10.1182/blood-52010-08-301275
80. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med (2007) 204(8):1765-74. doi:10.1084/jem.20070719
81. Lu L, Ma J, Li Z, Lan Q, Chen M, Liu Y, et al. All-17trans retinoic acid promotes TGF-beta-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS ONE (2011) 6(9):e24590. doi:10.1371/journal.pone.0024590
82. Martin-Gayo E, Sierra-Filardi E, Corbi AL, Toribio ML. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood (2010) 115(26):5366-75. doi:10.1182/blood-2009-10-248260
83. Coquet JM, Middendorp S, van der Horst G, Kind J, Veraar EA, Xiao Y, et al. The CD27 and CD70 costimulatory pathway inhibits effector function of T helper 17 cells and attenuates associated autoimmunity. Immunity (2013) 38(1):53-65. doi:10.1016/j.immuni.2012.09.009
84. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med (2007) 204(8):1775-85. doi:10.1084/jem.20070602
85. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med (2007) 204(8):1757-64.
86. + regulatory T cells. J Immunol (2008) 181(10):6923-33.
87. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-17beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med (2005) 201(7):1061-7. doi:10.1084/jem.20042276
88. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol (2007) 5(2):e38. doi:10.1371/journal.pbio.0050038
89. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol (2007) 37(9):2378-89. doi:10.1002/eji.200737594
90. Zhou X, Bailey-106Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol (2009) 10(9):1000-7. doi:10.1038/ni.1774
91. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity (2008) 29(1):44-56. doi:10.1016/j.immuni.2008.05.007
92. Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, Mathis D, et al. Stability of the regulatory T cell lineage in vivo. Science (2010) 329(5999):1667-71. doi:10.1126/science.1191996
93. Sakaguchi S, Vignali DA, Rudensky AY, Niec RE, Waldmann H. The plasticity and stability of regulatory T cells. Nat Rev Immunol (2013) 13(6):461-7. doi:10.1038/nri3464
94. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-100cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood (2007) 110(8):2983-90. doi:10.1182/blood-2007-06-094656
95. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol (2007) 19(4):345-54. doi:10.1093/intimm/dxm014
96. McMurchy AN, Gillies J, Gizzi MC, Riba M, Garcia-3Manteiga JM, Cittaro D, et al. A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells. Blood (2013) 121(8):1265-75. doi:10.1182/blood-2012-05-431023
97. McMurchy AN, Levings MK. In vitro generation of human T regulatory cells: generation, culture, and analysis of FOXP3-transduced T cells. Methods Mol Biol (2013) 946:115-32. doi:10.1007/978-1-62703-128-8_8
98. + regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol (2007) 179(7):4685-93.
99. Nguyen TL, Sullivan NL, Ebel M, Teague RM, DiPaolo RJ. Antigen-46specific TGF-beta-induced regulatory T cells secrete chemokines, regulate T cell trafficking, and suppress ongoing autoimmunity. J Immunol (2011) 187(4):1745-53. doi:10.4049/jimmunol.1004112
100. + T cells in vivo. J Immunol (2011) 186(11):6329-37. doi:10.4049/jimmunol.1100061
101. + inducible regulatory T cell stability by SOCS2. J Immunol (2013) 190(7):3235-45. doi:10.4049/jimmunol.1201396
102. van der Touw W, Cravedi P, Kwan WH, Paz-63Artal E, Merad M, Heeger PS. Cutting edge: receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. J Immunol (2013) 190(12):5921-5. doi:10.4049/jimmunol.1300847
103. + Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol (2009) 39(11):3091-6. doi:10.1002/eji.200939432
104. Guerin LR, Prins JR, Robertson SA. Regulatory T-309cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update (2009) 15(5):517-35. doi:10.1093/humupd/dmp004
105. Lee SK, Kim JY, Lee M, Gilman-Sachs A, Kwak-Kim J. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol
106. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology (2004) 112(1):38-43. doi:10.1111/j.1365-2567.2004.01869.x
107. Zhao JX, Zeng YY, Liu Y. Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod Immunol (2007) 75(2):71-81. doi:10.1016/j.jri.2007.06.052
108. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol (2004) 5(3):266-71. doi:10.1038/ni1037
109. Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, et al. Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol (2010) 85(2):121-9. doi:10.1016/j.jri
110. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod (2004) 10(5):347-53. doi:10.1093/molehr/gah044
111. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol (2007) 178(4):2572-8.
112. + regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reprod Immunol (2012) 68(2):175-80. doi:10.1111/j.1600-0897.2012.01145.x
113. Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, et al. Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol (2012) 181(6):2149-60. doi:10.1016/j.ajpath.2012.08.032
114. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-21fetal conflict. Cell (2012) 150(1):29-38. doi:10.1016/j.cell.2012.05.031
115. Ramhorst R, Fraccaroli L, Aldo P, Alvero AB, Cardenas I, Leiros CP, et al. Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol (2012) 67(1):17-27. doi:10.1111/j.1600-0897.2011.01056.x
116. Elkord E, Alcantar-Orozco EM, Dovedi SJ, Tran DQ, Hawkins RE, Gilham DE. T regulatory cells in cancer: recent advances and therapeutic potential. Expert Opin Biol Ther (2010) 10(11):1573-86. doi:10.1517/14712598.2010.529126
117. Wieckiewicz J, Goto R, Wood KJ. T regulatory cells and the control of alloimmunity: from characterisation to clinical application. Curr Opin Immunol (2010) 22(5):662-8. doi:10.1016/j.coi.2010.08.011
118. Tang Q, Bluestone JA, Kang SM. CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol (2012) 4(1):11-21. doi:10.1093/jmcb/mjr047
119. Hippen KL, Riley JL, June CH, Blazar BR. Clinical perspectives for regulatory T cells in transplantation tolerance. Semin Immunol (2011) 23(6):462-8. doi:10.1016/j.smim.2011.07.008
120. Blazar BR, Murphy WJ, Abedi M. Advances in graft-15versus-host disease biology and therapy. Nat Rev Immunol (2012) 12(6):443-58. doi:10.1038/nri3212
121. Hippen KL, Harker-4Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, et al. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood (2008) 112(7):2847-57. doi:10.1182/blood-2008-01-132951
122. Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity (2009) 30(5):656-65. doi:10.1016/j.immuni.2009.04.006
123. Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med (2011) 3(83):83ra41. doi:10.1126/scitranslmed.3001809
124. Hoffmann P, Boeld TJ, Eder R, Albrecht J, Doser K, Piseshka B, et al. Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant (2006) 12(3):267-74. doi:10.1016/j.bbmt.2006.01.005
125. Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-6haploidentical transplantation. Blood (2011) 117(14):3921-8. doi:10.1182/blood-2010-10-311894
126. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood (2011) 117(3):1061-70. doi:10.1182/blood-2010-07-293795
127. + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A (2009) 106(6):1903-8. doi:10.1073/pnas.0811556106
128. + T cells in gut Peyer's patches. Science (2009) 323(5920):1488-92. doi:10.1126/science.1169152
129. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25-190190Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol (2007) 178(11):6725-9.
130. Hippen KL, Merkel SC, Schirm DK, Nelson C, Tennis NC, Riley JL, et al. Generation and large-672scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant (2011) 11(6):1148-57. doi:10.1111/j.1600-6143.2011.03558.x
131. Schmitt EG, Haribhai D, Williams JB, Aggarwal P, Jia S, Charbonnier LM, et al. IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. J Immunol (2012) 189(12):5638-48. doi:10.4049/jimmunol.1200936
132. + regulatory T cells confer infectious tolerance in a TGF-56beta-dependent manner. J Exp Med (2008) 205(9):1975-81. doi:10.1084/jem.20080308